F-star Therapeutics Overview

F-star Therapeutics Total Revenue

Revenue analysis for FSTX.

Quarterly Revenue

$1.13M

↑ 49.8% YoY

As of Sep 2022

Annual Revenue (TTM)

$21.18M

↑ 452.73% YoY

Trailing 12 months ending Sep 2022

Average Revenue (Comparison Companies)

Total Revenue History

Total Revenue Comparison

Annual Revenue Growth Rate (%)

Annual Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin